XML 121 R15.htm IDEA: XBRL DOCUMENT v3.3.0.814
Restructuring and Related Charges
 12 Months Ended
Sep. 25, 2015
Restructuring and Related Activities [Abstract]  
Restructuring and Related Charges
6.
Restructuring and Related Charges
During fiscal 2013, the Company launched a restructuring program designed to improve its cost structure ("the 2013 Mallinckrodt Program"). The 2013 Mallinckrodt Program includes actions across all segments, as well as within corporate functions. The Company expects to incur charges of $100.0 million to $125.0 million under this program as the specific actions required to execute on these initiatives are identified and approved, most of which are expected to be incurred by the end of fiscal 2016.
Prior to Separation, Covidien initiated restructuring programs, which also applied to its Pharmaceutical business. These programs were substantially completed as of September 26, 2014.
Net restructuring and related charges by segment within continuing operations are as follows:
 
Fiscal Year
 
2015
 
2014
 
2013
Specialty Brands
$
36.5

 
$
57.0

 
$
5.2

Specialty Generics
4.5

 
9.8

 
11.2

Nuclear Imaging
(4.6
)
 
13.7

 
6.9

Corporate
4.3

 
1.4

 
3.0

Restructuring and related charges, net
40.7

 
81.9

 
26.3

Less: accelerated depreciation
(0.3
)
 
(0.5
)
 
(2.6
)
Restructuring charges, net
$
40.4

 
$
81.4

 
$
23.7



Net restructuring and related charges by program within continuing operations are comprised of the following:
 
Fiscal Year
 
2015
 
2014
 
2013
2013 Mallinckrodt Program
$
7.4

 
$
27.3

 
$
8.5

Acquisition programs
33.6

 
56.4

 
—

Other programs
(0.3
)
 
(1.8
)
 
17.8

Total programs
40.7

 
81.9

 
26.3

Less: non-cash charges, including impairments and accelerated share based compensation expense
(10.1
)
 
(38.0
)
 
(2.6
)
Total charges expected to be settled in cash
$
30.6

 
$
43.9

 
$
23.7



Non-cash charges in fiscal 2015 and fiscal 2014 include $9.8 million and $35.1 million, respectively, of accelerated share based compensation expense related to employee terminations, primarily related to our Questcor acquisition, and fiscal 2014 includes $2.3 million of property, plant and equipment asset impairments.
The following table summarizes cash activity for restructuring reserves, substantially all of which related to employee severance and benefits, with the exception of $8.5 million in fiscal 2014 related to consulting costs associated with restructuring initiatives related to the CMDS business:
 
2013 Mallinckrodt Program
 
Acquisition Programs
 
Other Programs
 
Total
Balance at September 28, 2012
$
—

 
$
—

 
$
8.9

 
$
8.9

Charges from continuing operations
8.5

 
—

 
17.6

 
26.1

Charges from discontinued operations
6.4

 
—

 
3.3

 
9.7

Changes in estimate from continuing operations
—

 
—

 
(2.4
)
 
(2.4
)
Changes in estimate from discontinued operations
—

 
—

 
(0.2
)
 
(0.2
)
Cash payments
—

 
—

 
(15.1
)
 
(15.1
)
Reclassifications (1)
—

 
—

 
(1.5
)
 
(1.5
)
Balance at September 27, 2013
14.9

 
—

 
10.6

 
25.5

Charges from continuing operations
32.9

 
22.9

 
1.4

 
57.2

Charges from discontinued operations
25.3

 
—

 
1.1

 
26.4

Changes in estimate from continuing operations
(7.6
)
 
(1.6
)
 
(4.1
)
 
(13.3
)
Changes in estimate from discontinued operations
(1.8
)
 
—

 
(0.7
)
 
(2.5
)
Cash payments
(34.8
)
 
(13.4
)
 
(6.8
)
 
(55.0
)
Reclassifications (1)
(1.3
)
 
—

 
(1.0
)
 
(2.3
)
Currency translation
(1.0
)
 
—

 
(0.1
)
 
(1.1
)
Balance at September 26, 2014
26.6

 
7.9

 
0.4

 
34.9

Charges from continuing operations
15.4

 
25.3

 
—

 
40.7

Charges from discontinued operations
1.0

 
—

 
—

 
1.0

Changes in estimate from continuing operations
(8.3
)
 
(1.5
)
 
(0.3
)
 
(10.1
)
Changes in estimate from discontinued operations
(0.6
)
 
—

 
—

 
(0.6
)
Cash payments
(22.5
)
 
(21.7
)
 
(0.1
)
 
(44.3
)
Reclassifications (1)
(3.0
)
 
—

 
—

 
(3.0
)
Currency translation
(0.6
)
 
—

 
—

 
(0.6
)
Balance at September 25, 2015
$
8.0

 
$
10.0

 
$
—

 
$
18.0


(1)
Represents the reclassification of pension and other postretirement benefits from restructuring reserves to pension and postretirement obligations.

Net restructuring and related charges, including associated asset impairments, incurred cumulative to date related to the 2013 Mallinckrodt Program are as follows:
Specialty Brands
$
4.0

Specialty Generics
15.6

Nuclear Imaging (including CMDS)
67.3

Corporate
10.0

 
$
96.9


Substantially all of the restructuring reserves are included in accrued and other current liabilities on the Company's consolidated balance sheets.